Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 21,643 | 16,806 | 23,088 | 17,214 | 17,981 |
| Operating Income | -21,643 | -16,806 | -23,088 | -17,214 | -17,981 |
| Interest Expense | 244 | 0 | 0 | 0 | 0 |
| Other Income | 2,096 | 6,798 | 5,340 | -210 | 899 |
| Pre-tax Income | -19,791 | -10,008 | -17,748 | -17,424 | -17,082 |
| Net Income Continuous | -19,791 | -10,008 | -17,748 | -17,424 | -17,082 |
| Net Income | $-19,791 | $-10,008 | $-17,748 | $-17,424 | $-17,082 |
| EPS Basic Total Ops | 0.00 | 0.00 | -5.69 | 0.00 | -20.00 |
| EPS Basic Continuous Ops | -1.66 | -2.04 | -5.68 | -8.12 | -10.81 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -5.69 | 0.00 | -20.00 |
| EPS Diluted Continuous Ops | -1.66 | -2.04 | -5.68 | -8.12 | -10.81 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.01 | -5.60 | -8.20 | -10.80 |
| EBITDA(a) | $-21,629 | $-16,802 | $-23,084 | $-17,210 | $-17,972 |